Edition:
United States

Zhejiang Hisun Pharmaceutical Co Ltd (600267.SS)

600267.SS on Shanghai Stock Exchange

11.16CNY
15 Aug 2018
Change (% chg)

¥-0.21 (-1.85%)
Prev Close
¥11.37
Open
¥11.37
Day's High
¥11.50
Day's Low
¥11.00
Volume
5,932,123
Avg. Vol
10,253,427
52-wk High
¥17.75
52-wk Low
¥10.40

Latest Key Developments (Source: Significant Developments)

Zhejiang Hisun Pharmaceutical receives GMP certificates
Monday, 7 May 2018 06:21am EDT 

May 7 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received goods manufacture practice (GMP) certificates from Zhejiang Food and Drug Administration .Certificate issued to crude drugs and antineoplastic drugs manufactured by the company and the valid period is until 2023 .  Full Article

Zhejiang Hisun Pharmaceutical to pay cash dividend of 0.5 yuan (pre-tax) for every 10 shares
Wednesday, 28 Mar 2018 12:53am EDT 

March 28 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it plans to pay a cash dividend of 0.5 yuan (pre-tax) for every 10 shares as the dividend payment plan for 2017.  Full Article

Zhejiang Hisun Pharmaceutical to swing to profit in FY 2017
Wednesday, 31 Jan 2018 05:45am EST 

Jan 31 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Sees to swing to net profit at 10 million yuan to 15 million yuan in FY 2017 versus net loss at 94.4 million yuan year ago.Says growth of main business and received compensation as well as government subsidies as main reasons for the forecast.  Full Article

Zhejiang Hisun Pharmaceutical and unit obtain high-tech enterprise recognition and to enjoy tax preference
Thursday, 4 Jan 2018 04:17am EST 

Jan 4(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it and unit were recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years .  Full Article

Zhejiang Hisun Pharmaceutical passes FDA approval
Tuesday, 21 Nov 2017 05:43am EST 

Nov 21(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received approval for a kind of tablet from U.S Food and Drug Administration .  Full Article

Zhejiang Hisun Pharmaceutical unit says product gets FDA approval
Monday, 20 Nov 2017 05:04am EST 

Nov 20(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says co's Hangzhou-based unit's product simvastatin tablets, gets approval from U.S. Food and Drug Administration.  Full Article

Zhejiang Hisun Pharmaceutical says product gets FDA approval
Thursday, 16 Nov 2017 02:35am EST 

Nov 16 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Says its product, mycophenolate mofetil capsules, gets approval from U.S. Food and Drug Administration .  Full Article

Zhejiang Hisun Pharmaceutical says change of CFO
Tuesday, 17 Oct 2017 10:58pm EDT 

Oct 18 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Says it appoints Liu Yuanyan as new CFO, replacing Guan Xuhua who resigns from the position due to internal change in job role.  Full Article

Zhejiang Hisun Pharmaceutical receives TGA-GMP certificate
Wednesday, 11 Oct 2017 04:20am EDT 

Oct 11 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received goods manufacture practice (GMP) certificate from Therapeutic Goods Administration .Certificate issued to crude drugs manufactured by the company and the valid period is until Nov. 26, 2020 .  Full Article

Zhejiang Hisun Pharmaceutical sub-subsidiary passes FDA approval
Monday, 11 Sep 2017 10:30am EDT 

Sept 11(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::* Says its Zhejiang-based sub-subsidiary received FDA approval for metformin sustained release tablet from U.S Food and Drug Administration .* Company will be able to sell its metformin sustained release tablet in the United States after receiving the FDA approval.  Full Article